Order Governing Federal Xarelto Lawsuits Allows Electronic Filing of Plaintiff, Defense Fact Sheets

Share Article

Bernstein Liebhard LLP is representing plaintiffs in federal Xarelto lawsuits, and this new order will further facilitate the efficient progress of these cases.

Free Case Review
Our Firm is representing clients in this proceeding, and we are pleased that these cases are moving forward.

Hundreds of federally-filed Xarelto lawsuits (http://www.xareltolawsuit2015.com/) involving the drug’s alleged association with uncontrollable internal bleeding and other serious complications continue to move forward in the federal multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana. According to a Pretrial Order dated June 23rd, all of the parties involved in the proceeding have agreed to accept online submission of Plaintiff and Defendant Fact Sheets via the online MDL Centrality System. (In Re: Xarelto Products Liability Litigation, No. 2592)

“Our Firm is representing clients in this proceeding, and we are pleased that these cases are moving forward. The protocols for online submissions set forth in this Order will promote judicial economy and further facilitate the efficient progress of federally-filed Xarelto lawsuits,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is actively filing Xarelto lawsuits in U.S. courts, and continues to evaluate claims on behalf of individuals who allegedly suffered life-threatening internal bleeding and other dangerous complications related to its use.

Xarelto Litigation
Court records indicate that more than 550 Xarelto lawsuits are pending in the multidistrict litigation now underway in the Eastern District of Louisiana. All of the claims were filed on behalf of individuals who allegedly suffered dangerous episodes of internal bleeding, strokes, deep vein thrombosis, pulmonary embolism, or other serious complications due to their use of the blood thinning medication. All of the plaintiffs involved in this litigation accuse the drug’s manufacturers of failing to provide adequate warnings regarding its risks, including the fact that their currently exists no approved antidote for reversing the internal bleeding sometimes associated with its use. They also allege that the manufacturers wrongly positioned Xarelto as an improvement over warfarin, a blood thinner that has been in use for decades. Among other things, the lawsuits point out that unlike Xarelto, internal bleeding associated with warfarin can be reversed with the administration of vitamin K.

According to court documents, Xarelto is a new-generation anticoagulant that was approved by the U.S. Food & Drug Administration in 2011, and is now indicated for the prevention of strokes in people with atrial fibrillation; the treatment of deep vein thrombosis and pulmonary embolism; and the prevention of deep vein thrombosis in patients undergoing hip or knee replacement surgery. The Xarelto label includes a black box warning that contains information about the increased risk of blood clot formation after premature discontinuation of the medication in the absence of adequate alternative anticoagulation.*

Individuals who experienced dangerous internal bleeding and other serious complications allegedly related to the use of Xarelto may be entitled to join this litigation. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.

*accessdata.fda.gov/drugsatfda_docs/label/2013/022406s004lbl.pdf, FDA, March 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website